Key facts
- This page summarizes Freda Lewis-Hall's Form 3 filing for Helus Pharma Inc. (HELP).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 26 Oct 2026, 13:49.
Freda Lewis-Hall - 13 Oct 2026 Form 3 Insider Report for Helus Pharma Inc. (HELP)
- Reporting relationship
- Director
- Issuer ticker
- HELP
- Reported as of
- 13 Oct 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 26 Oct 2026, 13:49:06 UTC
- Prior SEC filing
- 25 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Freda Lewis-Hall
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Freda Lewis-Hall filed Form 3 for Helus Pharma Inc. (HELP) on 26 Oct 2026.
Change
- Previous filing in this sequence was filed on 25 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001437909
Primary reporting owner
Lewis-Hall Freda C
- Relationship
- Director
- Address
- C/O HELUS PHARMA INC., 100 KING STREET W., SUITE 5600, TORONTO, ONTARIO, CANADA
- Signature
- /s/ Freda Lewis-Hall
- Signature date
- 26 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HELP
holding
Common Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,000
- Date
- 13 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HELP
holding
Derivative
Options ("Right to Buy")
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Oct 2026
- Ownership
- Held by Intelmed, LLC
- Underlying class
- Common Shares
- Underlying amount
- 25,000
- Exercise price
- $5.99
- Footnotes
- F1, F2, F3
HELP
holding
Derivative
Restricted Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 13 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 25,000
- Exercise price
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The options vest quarterly over two years, commencing on December 31, 2025.
Footnote F2
Converted from Canadian exercise price of C$8.39 using an exchange rate of C$1.40 = US$1.00.
Footnote F3
Intelmed, LLC is a limited liability company owned and controlled by the reporting person.
Footnote F4
The restricted share units ("RSUs") vest on November 20, 2026.
Footnote F5
Each RSU represents a right to receive one Issuer common share.